FACL4 (17M4) Rabbit Monoclonal Antibody

FACL4 (17M4) Rabbit Monoclonal Antibody

Cat: AMRe10779
Boyut:50μL Fiyat:$128_x000D_
Boyut:100μL Fiyat:$230_x000D_
Boyut:200μL Fiyat:$380_x000D_
Uygulama:WB,IHC,ICC/IF
Reaktivite:Human
Konjuge:Unconjugated
İsteğe bağlı konjugeler: Biotin, FITC (ücretsiz). Diğer 26 konjugatı görün.

Gen Adı:ACSL4
Category: 組換えモノクローナル抗体 Tags: , , , , , , ,
FACL4 (17M4) Rabbit Monoclonal Antibody
Konjugasyon: Unconjugated
Recombinant rabbit monoclonal antibody
Uygulama
IHC  ICC/IF  ELISA WB,IHC,ICC/IF
Reaktivite
Human
Gen Adı
ACSL4
Saklama
Aliquot and store at -20°C (valid for 12 months). Avoid freeze/thaw cycles.
Özet
Ürün Adı FACL4 (17M4) Rabbit Monoclonal Antibody
Açıklama Recombinant rabbit monoclonal antibody
Konak Rabbit
Reaktivite Human
Konjugasyon Unconjugated
Modifikasyon Unmodified
İzotip IgG
Klonalite Monoclonal
Form Liquid
Konsantrasyon Unconjugated
Saklama Aliquot and store at -20°C (valid for 12 months). Avoid freeze/thaw cycles.
Nakliye Ice bags.
Tampon Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% New type preservative N and 0.05% protective protein.
Saflaştırma Affinity purification
Antijen Bilgisi
Gen Adı ACSL4
Alternatif İsimler ACS4; Acsl4; acyl CoA synthetase 4; FACL4; Fatty acid Coenzyme A ligase; LACS4; Long chain 4; long chain fatty acid Coenzyme A ligase 4; MRX63; MRX68;
Gen Kimliği 2182
SwissProt Kimliği O60488
İmmünojen Recombinant protein of human FACL4
Uygulama
Uygulama WB,IHC,ICC/IF
Seyreltme Oranı WB 1:500-1:2000,IHC 1:100-1:200,ICC/IF 1:20-1:50
Moleküler Ağırlık 79kDa
Araştırma Alanı
Signal Transduction
Arka Plan
Activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. Preferentially uses arachidonate and eicosapentaenoate as substrates. Catalyzes the conversion of long-chain fatty acids to their active form acyl-CoA for both synthesis of cellular lipids, and degradation via beta-oxidation (PubMed:24269233, PubMed:22633490, PubMed:21242590). Preferentially activates arachidonate and eicosapentaenoate as substrates (PubMed:21242590). Preferentially activates 8,9-EET > 14,15-EET > 5,6-EET > 11,12-EET. Modulates glucose- stimulated insulin secretion by regulating the levels of unesterified EETs (By similarity). Modulates prostaglandin E2 secretion (PubMed:21242590).
   💬 WhatsApp